Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.82 |
| ▸ | HTT | P42858 | 1/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.73 |
| ▸ | TAS1R3 | Q7RTX0 | 6/20 | 0.73 |
| ▸ | TAS1R1 | Q7RTX1 | 6/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6570868 | 0.92 | LMNA (0.69) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL2406255 | 0.90 | HTT (1.00) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL5436807 | 0.90 | HTT (1.00) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL21780113 | 0.89 | HTT (0.82) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL10527008 | 0.88 | HTT (0.80) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL30823638 | 0.88 | HTT (0.84) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL22289415 | 0.88 | HTT (0.84) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| Hydrochloric Acid SCHEMBL10528633 | 0.86 | HTT (0.78) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL12505792 | 0.85 | HTT (0.80) | LMNAKMT2AHTTALDH1A1TAS1R3 | |
| SCHEMBL703278 | 0.84 | TAS1R3 (1.00) | LMNAKMT2AHTTALDH1A1TAS1R3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040214862-A1 | Aromatic dicarboxylic acid derivatives | LESER-REIFF ULRIKE | 2004-10-28 | — | — | US | claimed |
| US-20030013757-A1 | Aromatic dicarboxylic acid derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-16 | — | — | US | claimed |
| US-20040214862-A1 | Aromatic dicarboxylic acid derivatives | LESER-REIFF ULRIKE | 2004-10-28 | — | — | US | disclosed |
| US-6784173-B2 | ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. | 2004-08-31 | — | — | US | disclosed |
| EP-1401824-A2 | AROMATIC HYDROXAMIC ACID DERIVATIVES USEFUL AS HDAC INHIBITORS | F. Hoffman-la Roche AG (CH) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003011851-A2 | AROMATIC HYDROXAMIC ACID DERIVATIVES USEFUL AS HDAC INHIBITORS | F. HOFFMAN-LA ROCHE AG (CH) | 2003-02-13 | — | — | WO | disclosed |
| US-20030013757-A1 | Aromatic dicarboxylic acid derivatives | HOFFMANN-LA ROCHE INC. | 2003-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214862-A1 | Aromatic dicarboxylic acid derivatives | HDAC1, HDAC2, HDAC11 | LMNA 2341/4885KMT2A 43/4885HTT 2354/4885 |
| US-20030013757-A1 | Aromatic dicarboxylic acid derivatives | HDAC1, HDAC2, HDAC11 | LMNA 2341/4885KMT2A 43/4885HTT 2354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.